Decision Diagnostics Corp (OTCMKTS:DECN) has signed a four-year agreement with Retail Monster as it seeks to attract big box retailers for its GenUltimate products.
Terms of the Agreement
The agreement tasks Retail Monster with the responsibility of executing and managing all Decision Diagnostics contracts related to the Gen family products. The company is also tasked with the responsibility of initiating and finalizing agreements that have the potential of discovering new markets for the diabetic test strips.
Retail Monster is a perfect fit for Decision Diagnostics Corp (OTCMKTS:DECN) given that it comes with a proven record of creating and presenting exciting brands on various retail outlets. The partnership is what the maker of GenUltimate glucose test strips needs the most as it looks to expand the addressable market of its latest products.
Buoyed by the agreement Decision Diagnostics Corp (OTCMKTS:DECN) Principal Executive, Keith Berman, says Retail Monster has what it takes to manage the company’s massive retail contract. The executive is also confident of the distributor’s ability to present the Gen products throughout the retail environment as well as in unexplored retail avenues.
“Their management and staff are deeply experienced in the retail market with impressive success moving brands from obscurity to presence, growth, and rapid expansion,” said Mr. Berman.
Founder and co-founder of Retail Monster, Michael Connolly, has also echoed his support for the partnership. Connolly says they have already identified 17 retailers across the US and Canada as potential retail collaborates that will carry the products. However, the primary goal is to have the products available in all the major retail outlets across the globe.
Apart from being available in North America Berman remains confident of the Gen products finding their way into international markets. Some of the marketplaces that Decision Diagnostics Corp (OTCMKTS:DECN) is eyeing include the United Kingdom, France and Spain.